Dongmei He

Dongmei He

Auto-generated profile, based on publicly available information

Dongmei He

Department of Oral Surgery Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2020 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
HZHuimin Zhu
Huimin Zhu
YHYihui Hu
Yihui Hu
CWChuandong Wang
Chuandong Wang
XZXiaoLing Zhang
XiaoLing Zhang
DHDongmei He
Dongmei He
Altered expression of circular RNAs (circRNAs) has been identified in various human diseases. In this study, we investigated whether circRNAs function as competing endogenous RNAs to regulate the pathological process of temporomandibular joint osteoarthritis (TMJOA). High-throughput sequencing of mRNA (RNA seq) was performed to detect the expression of circRNAs in TMJOA and control synovial tissues isolated from humans. The differentially upregulated circGCN1L1 (hsa_circ_0000448) in synoviocyte was validated in vitro and in vivo. Here we demonstrate the interactions between circGCN1L1 and both miR-330-3p and tumor necrosis factor-α (TNF-α) through bioinformatics predictions, luciferase report assays, and fluorescence in situ hybridization. mRNA expression profiles of TNF-α-stimulated synoviocyte showed that circGCN1L1 and p65 expressions were upregulated by TNF-α. Moreover, miR-330-3p was negatively correlated with TNF-α secretion. Further, we found that miR-330-3p directly targeted TNF and restrained the production of matrix-degrading enzymes (MMP3, MMP13, and ADAMTS4). Mechanistic studies unveiled that circGCN1L1 in TMJOA synovial tissues and cells may be associated with condylar chondrocyte apoptosis and synoviocyte hyperplasia. Moreover, intra-articular injection of shcircGCN1L1 alleviated TMJOA progression in rat models. Altogether, we elucidated the important roles of a novel circRNA, namely, circGCN1L1, which induced inflammation in TMJ synoviocytes and decreased anabolism of the extracellular matrix (ECM) through miR-330-3p and TNF-α gene. This circRNA may represent a potentially effective therapeutic strategy against TMJOA progression at an early stage.

1 February 2018 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
LZLuxiang Zou
Luxiang Zou
DHDongmei He
Dongmei He
EEEdward Ellis
Edward Ellis

1 January 2015 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
QXQianyang Xie
Qianyang Xie
Chi YangChi Yang
Chi Yang
DHDongmei He
Dongmei He
XCXieyi Cai
Xieyi Cai
ZMZhigui Ma
Zhigui Ma

1 December 2014 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
GBGuo Bai
Guo Bai
DHDongmei He
Dongmei He
CYChi Yang
Chi Yang
MCMinjie Chen
Minjie Chen
JYJianbing Yuan
Jianbing Yuan
JWJulian J. Wilson
Julian J. Wilson

1 January 2015 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
DHDongmei He
Dongmei He
CYChi Yang
Chi Yang
SZShanyong Zhang
Shanyong Zhang
JWJulian J. Wilson
Julian J. Wilson

3 February 2023 in Materials Today Bio
Verified
Journal Article
Open access
YZYingqian Zhong
Yingqian Zhong
YZYuyu Zhou
Yuyu Zhou
RDRuoyi Ding
Ruoyi Ding
LZLuxiang Zou
Luxiang Zou
Hongyu ZhangHongyu Zhang
Hongyu Zhang
DHDongmei He
Dongmei He
Temporomandibular joint (TMJ) osteoarthritis is a common osteochondral degenerative disease which can severely affect patient's mouth opening and mastication. Meloxicam (MLX), one of the most widely used non-steroidal anti-inflammatory drugs, is the main clinical therapy for the treatment of TMJ osteoarthritis. However, the clinical effect is greatly compromised because of its poor water solubility and high lipophilicity. In the present study, we developed an actively-loaded liposomal formulation, namely MLX-Ca(AC)2Lipo, using meglumine to enhance aqueous solubility and divalent metal (Ca2+) solution to improve encapsulation efficiency. By the formation of the nano-bowl shaped MLX-Ca precipitates inside the liposomes, MLX-Ca(AC)2Lipo successfully achieved an optimal encapsulation efficiency as high as 98.4% compared with previous passive loading method (60.6%). Additionally, MLX-Ca(AC)2Lipo maintained stable, and the slow drug release not only prolonged the duration of drug efficacy but also improved bioavailability. It was shown in the in vitro and in vivo tests that MLX-Ca(AC)2Lipo downregulated the synthesis of the inflammatory factors (such as prostaglandin-E2) and as a consequence reduced chondrocytes apoptosis and extracellular matrix degeneration. Furthermore, the intra-articular injection of MLX-Ca(AC)2Lipo enhanced bioinspired lubrication of TMJ, protecting the cartilage from progressive wear. In summary, MLX-Ca(AC)2Lipo with dual-functions of anti-inflammation and lubrication is a promising nanomedicine for the treatment of TMJ osteoarthritis by intra-articular injection.